DarioHealth
DRIO • NASDAQ
DarioHealth is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Erez Raphael, with a market cap of $59.2M.
CEOErez Raphael
Next Earnings
Upcoming earnings announcement for DarioHealth
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (6:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.95
Revenue Estimate
$5.3M
Earnings History
Past 12 earnings reports for DarioHealth
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q4 2025 | -$0.82Est: -$1.67 | +51.1% | $5.2MEst: $5.1M | +2.4% | — |
| Nov 13, 2025 | Q3 2025 | -$1.91Est: -$3.03 | +37.0% | $5.0MEst: $5.7M | -12.0% |  10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.21Est: -$0.14 | -46.4% | $5.4MEst: $6.9M | -22.2% | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.12Est: -$0.05 | -140.0% | $6.8MEst: $7.5M | -9.6% | 10-Q |
| Mar 10, 2025 | Q4 2024 | -$0.04Est: -$0.14 | +71.4% | $7.6MEst: $7.4M | +2.9% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.18Est: -$0.27 | +33.3% | $7.4MEst: $7.4M | +0.3% | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.20Est: -$0.55 | +63.6% | $6.3MEst: $7.9M | -20.9% | 10-Q |
| May 15, 2024 | Q1 2024 | -$0.20Est: -$0.40 | +50.0% | $5.8MEst: $6.8M | -14.8% | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.41Est: -$0.54 | +24.1% | $3.6MEst: $3.6M | +1.3% | 10-K |
| Nov 2, 2023 | Q3 2023 | -$0.49Est: -$0.46 | -6.5% | $3.5MEst: $5.3M | -34.1% | — |
| Aug 10, 2023 | Q2 2023 | -$0.58Est: -$0.52 | -11.5% | $6.2MEst: $6.5M | -4.8% | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.45Est: -$0.50 | +10.0% | $7.1MEst: $6.7M | +5.5% | 10-Q |